Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

JAE Irving, A Enshaei, CA Parker… - Blood, The Journal …, 2016 - ashpublications.org
Somatic genetic abnormalities are initiators and drivers of disease and have proven clinical
utility at initial diagnosis. However, the genetic landscape and its clinical utility at relapse are …

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukaemia

JAE Irving, A Enshaei, C Parker, R Sutton… - …, 2016 - research.manchester.ac.uk
Somatic genetic abnormalities are initiators and drivers of disease and have proven clinical
utility at initial diagnosis. However, the genetic landscape and its clinical utility at relapse is …

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

J Irving, A Enshaei, C Parker, R Sutton, R Kuiper… - 2016 - digital.library.adelaide.edu.au
Somatic genetic abnormalities are initiators and drivers of disease and have proven clinical
utility at initial diagnosis. However, the genetic landscape and its clinical utility at relapse are …

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

JAE Irving, A Enshaei, CA Parker, R Sutton, RP Kuiper… - Blood, 2016 - cir.nii.ac.jp
抄録< jats: title> Key Points</jats: title>< jats: p> Chromosomal abnormalities predict
outcome after relapse in BCP-ALL, and high-risk cytogenetics takes precedence over …

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukaemia.

J Irving, A Enshaei, C Parker, R Sutton, R Kuiper… - Blood, 2016 - ora.ox.ac.uk
Somatic genetic abnormalities are initiators and drivers of disease and have proven clinical
utility at initial diagnosis. However, the genetic landscape and its clinical utility at relapse is …

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

JAE Irving, A Enshaei, CA Parker, R Sutton… - Blood, 2016 - pure.johnshopkins.edu
Somatic genetic abnormalities are initiators and drivers of disease and have proven clinical
utility at initial diagnosis. However, the genetic landscape and its clinical utility at relapse are …

[HTML][HTML] Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

JAE Irving, A Enshaei, CA Parker, R Sutton, RP Kuiper… - Blood, 2016 - ncbi.nlm.nih.gov
Somatic genetic abnormalities are initiators and drivers of disease and have proven clinical
utility at initial diagnosis. However, the genetic landscape and its clinical utility at relapse are …

[PDF][PDF] Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

JAE Irving, A Enshaei, CA Parker, R Sutton, RP Kuiper… - 2016 - academia.edu
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease at the genetic level, and
the spectrum of somatic aberrations range from chromosomal abnormalities to …

[PDF][PDF] Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia

JAE Irving, A Enshaei, CA Parker, R Sutton, RP Kuiper… - 2016 - researchgate.net
Acute lymphoblastic leukemia (ALL) is a heterogeneous disease at the genetic level, and
the spectrum of somatic aberrations range from chromosomal abnormalities to …

Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia.

JA Irving, A Enshaei, CA Parker, R Sutton, RP Kuiper… - Blood, 2016 - europepmc.org
Somatic genetic abnormalities are initiators and drivers of disease and have proven clinical
utility at initial diagnosis. However, the genetic landscape and its clinical utility at relapse are …